United States · FDA National Drug Code directory
Hydroxyzine Pamoate
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 71335-1923_7142bcf3-e30c-41ec-824a-a9f4f0041046
- Product NDC
- 71335-1923
- Form
- CAPSULE
- Composition / generic term
- Hydroxyzine Pamoate
- Labeler
- Bryant Ranch Prepack
- Marketing category
- ANDA
- Marketing start / end (source format)
- 19960615
- Source listing expiry
- 20261231
Source-listed ingredients
- HYDROXYZINE PAMOATE — 50 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 CAPSULE in 1 BOTTLE, PLASTIC (71335-1923-1) · 71335-1923-1
- 60 CAPSULE in 1 BOTTLE, PLASTIC (71335-1923-2) · 71335-1923-2
- 90 CAPSULE in 1 BOTTLE, PLASTIC (71335-1923-3) · 71335-1923-3
- 8 CAPSULE in 1 BOTTLE, PLASTIC (71335-1923-4) · 71335-1923-4
- 20 CAPSULE in 1 BOTTLE, PLASTIC (71335-1923-5) · 71335-1923-5
- 42 CAPSULE in 1 BOTTLE, PLASTIC (71335-1923-6) · 71335-1923-6
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →